Effect of tableting temperature on tablet properties and dissolution behavior of heat sensitive formulations.

Disintegration Dissolution Heated tableting Percolation Tabletability

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
15 Dec 2023
Historique:
received: 05 10 2023
revised: 03 11 2023
accepted: 11 11 2023
medline: 5 12 2023
pubmed: 16 11 2023
entrez: 15 11 2023
Statut: ppublish

Résumé

The tableting process involves the conversion of mechanical to thermal energy. This study evaluated the influence of temperature on the tableting behavior of formulations with different compositions. The tableting machine was equipped with a thermally controlled die to mimic the heat evolution from tableting on an industrial scale. Six formulations containing binders with a comparably low glass transition temperature were examined. Besides the polymer type and concentration, the filler was varied. Paracetamol was chosen as the model active pharmaceutical ingredient. The investigation included alterations in tabletability, disintegration and dissolution. Elevated temperatures led to an enhanced tabletability. The polymer type and concentration were decisive for the extent of alterations. The variation of the filler composition played a minor role due to the high melting points of its components. The results were confirmed in disintegration and dissolution studies. A high binding capacity and a low glass transition temperature resulted in a stronger delay of disintegration. The dissolution was sustained. Increased concentrations of the binding polymer enhanced the effect. If the tableting behavior of a formulation is changed by elevated temperatures during formulation development and production, a change of the binder type or concentration should be considered to ensure a reproducible tablet quality.

Identifiants

pubmed: 37967689
pii: S0378-5173(23)01024-4
doi: 10.1016/j.ijpharm.2023.123603
pii:
doi:

Substances chimiques

Excipients 0
Tablets 0
Polymers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

123603

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Hanna Dorothea Grumann (HD)

Heinrich Heine University, Institute of Pharmaceutics and Biopharmaceutics, Universitaetsstraße 1, 40225 Duesseldorf, Germany.

Peter Kleinebudde (P)

Heinrich Heine University, Institute of Pharmaceutics and Biopharmaceutics, Universitaetsstraße 1, 40225 Duesseldorf, Germany. Electronic address: kleinebudde@hhu.de.

Articles similaires

Semiconductors Photosynthesis Polymers Carbon Dioxide Bacteria
Silicon Dioxide Water Hot Temperature Compressive Strength X-Ray Diffraction
Animals Huntington Disease Mitochondria Neurons Mice

Classifications MeSH